Samsung Bioepis is set to launch OBODENCE™ (60 mg pre-filled syringe) and XBRYK™ (120 mg vial). These products are denosumab biosimilars from Prolia and...
Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the...
LenioBio and mAIbe have entered into a strategic collaboration designed to accelerate the discovery and experimental validation of next-generation monoclonal antibodies by uniting their...
Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the...
Scientist.com, the life sciences industry’s leading AI-enabled R&D orchestration platform, and GHO Capital Partners LLP (“GHO”), the specialist private equity investor in global healthcare,...
